Pfizer chairman and CEO Albert Bourla said ... FDA approves Pfizer-BioNTech’s Omicron XBB.1.5-adapted Covid-19 vaccine was originally created and published by Pharmaceutical Technology ...

BioNTech CEO Sahin says a new vaccine will probably be needed by the middle of next year to fight off Covid variants. BioNTech (BNTX) Chief Executive Ugur Sahin says a new vaccine will ...

BioNTech CEO Ugur Sahin suggested that countries ... at least for repression of severe disease.” OMICRON-SPECIFIC VACCINE The World Health Organization classified Omicron on Nov. 26 as a ...

Hong Kong will have another choice for a Covid-19 vaccine targeting the Omicron variant, with drug maker BioNTech offering to make its second-generation jabs available in the city as early as ...

Moderna CEO Stéphane Bancel ... in the effectiveness of Pfizer-BioNTech versus omicron after just a few months creates new challenges." Dr. Paul Offit, a vaccine expert at the Children’s ...

Pfizer’s CEO Albert Bourla said ... People in Great Britain will be able to buy the latest Omicron-directed version of Pfizer/BioNTech’s COVID-19 vaccine from retail pharmacies, starting ...

BioNTech’s CEO said the company and partner Pfizer don’t need to halt their late-stage trial of a coronavirus vaccine due to side effects. The side effects that have cropped up in its study ...

Pfizer’s CEO Albert Bourla said ... People in Great Britain will be able to buy the latest Omicron-directed version of Pfizer/BioNTech’s COVID-19 vaccine from retail pharmacies, starting ...

The FDA's actions Monday related just to the vaccines manufactured by Moderna and Pfizer-BioNTech. Both of their vaccines ...

BioNtech-Pfizer has promised to deliver up to 75 million more coronavirus vaccine doses to the EU in the second quarter of 2021, the company's head Sierk Poetting said in a statement on Monday.

BioNTech said that with Pfizer, it delivered their Omicron XBB.a.5-adapted COVID-19 vaccine. In 2023, the companies delivered more than 400 million COVID-19 vaccine doses worldwide, down from ...

Ugur Sahin, M.D., CEO and Co-Founder of BioNTech ... Key Post Period-End Events and 2024 Outlook Omicron XBB.1.5-adapted Monovalent COVID-19 Vaccine (COMIRNATY®) BioNTech and Pfizer developed ...